Vistin Pharma ASA (VISTN) Earnings Call Transcripts
About Vistin Pharma ASA
Vistin Pharma ASA (VISTN) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on OB and is based in NO. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 21 calls on record spanning August 19, 2021 to August 20, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 21 Vistin Pharma ASA earnings call transcripts on record, spanning August 19, 2021 to August 20, 2026. Based on this history, Vistin Pharma ASA reports quarterly. The most recent call on file is dated August 20, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- VISTN
- Exchange
- OB
- Country
- NO
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Calls on record
- 21
- First call
- August 19, 2021
- Most recent
- August 20, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q2 FY2026 | Aug 20, 2026 | Read transcript → |
| Q1 FY2026 | Apr 24, 2026 | Read transcript → |
| Q4 FY2025 | Feb 12, 2026 | Read transcript → |
| Q3 FY2025 | Oct 31, 2025 | Read transcript → |
| Q2 FY2025 | Aug 15, 2025 | Read transcript → |
| Q1 FY2025 | Apr 25, 2025 | Read transcript → |
| Q4 FY2024 | Feb 13, 2025 | Read transcript → |
| Q3 FY2024 | Oct 31, 2024 | Read transcript → |
| Q2 FY2024 | Aug 23, 2024 | Read transcript → |
| Q1 FY2024 | Apr 24, 2024 | Read transcript → |
| Q4 FY2023 | Feb 16, 2024 | Read transcript → |
| Q3 FY2023 | Oct 25, 2023 | Read transcript → |
| Q2 FY2023 | Aug 23, 2023 | Read transcript → |
| Q1 FY2023 | Apr 27, 2023 | Read transcript → |
| Q4 FY2022 | Feb 17, 2023 | Read transcript → |
| Q3 FY2022 | Oct 26, 2022 | Read transcript → |
| Earnings Calls | Aug 19, 2022 | Read transcript → |
| Q1 FY2022 | Apr 27, 2022 | Read transcript → |
| Q4 FY2021 | Feb 17, 2022 | Read transcript → |
| Q3 FY2021 | Oct 28, 2021 | Read transcript → |
| Q2 FY2021 | Aug 19, 2021 | Read transcript → |